沃森生物
(300142)
| 流通市值：208.28亿 | | | 总市值：211.11亿 |
| 流通股本：15.78亿 | | | 总股本：15.99亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 767,444,963.33 | 970,096,257.6 | 1,352,716,119.41 | 1,681,419,365.41 |
| 应收票据及应收账款 | 2,008,142,978.43 | 2,287,937,763.46 | 2,145,431,189.17 | 2,283,925,049.27 |
| 应收账款 | 2,008,142,978.43 | 2,287,937,763.46 | 2,145,431,189.17 | 2,283,925,049.27 |
| 预付款项 | 53,305,109.53 | 22,842,864.39 | 18,690,274.42 | 27,792,060.43 |
| 其他应收款合计 | 93,166,917.07 | 80,591,622.69 | 79,300,123.43 | 80,308,253.88 |
| 应收股利 | 3,131,258.13 | - | - | - |
| 存货 | 602,415,075.56 | 561,735,891.33 | 574,159,308.36 | 545,002,619.18 |
| 一年内到期的非流动资产 | 425,603,247.79 | 317,432,585.67 | 315,747,666.47 | 313,910,166.5 |
| 其他流动资产 | 95,690,354.6 | 88,408,654.2 | 60,288,303.39 | 979,925,194.68 |
| 流动资产合计 | 4,045,768,646.31 | 4,329,045,639.34 | 4,546,332,984.65 | 5,912,282,709.35 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | 3,674,511.89 | 3,603,523.76 |
| 长期股权投资 | 148,664,209.23 | 64,104,472.85 | 14,342,643.33 | 14,571,792.97 |
| 其他权益工具投资 | - | - | 506,661,256.18 | 474,714,408.93 |
| 其他非流动金融资产 | 422,458,048.05 | 409,897,860.13 | 428,955,560.13 | 495,700,000 |
| 投资性房地产 | 22,042,851.89 | 22,220,222.41 | 22,915,703.82 | 23,352,129.7 |
| 固定资产 | 1,730,656,166.51 | 1,692,174,688.18 | 1,721,952,437.63 | 1,776,835,253.2 |
| 在建工程 | 2,255,704,406.74 | 2,300,247,856.52 | 2,284,085,833.95 | 2,235,887,836.38 |
| 使用权资产 | 16,073,994.21 | 22,594,843.95 | 26,299,527.36 | 29,716,440.31 |
| 无形资产 | 834,279,483.57 | 816,960,539.17 | 831,432,655.91 | 858,233,546.85 |
| 开发支出 | 583,268,522.87 | 557,933,110.75 | 540,159,139.79 | 506,742,695.87 |
| 商誉 | 33,657,636.81 | 33,657,636.81 | 33,657,636.81 | 33,657,636.81 |
| 长期待摊费用 | 52,817,931.97 | 50,592,961.38 | 46,240,044.75 | 49,146,720.97 |
| 递延所得税资产 | 107,121,765.15 | 106,933,933.14 | 110,810,469.84 | 103,843,701.01 |
| 其他非流动资产 | 247,366,630.68 | 721,920,940.13 | 953,068,835.22 | 733,576,520.58 |
| 非流动资产合计 | 6,454,111,647.68 | 6,799,239,065.42 | 7,524,256,256.61 | 7,339,582,207.34 |
| 资产总计 | 10,499,880,293.99 | 11,128,284,704.76 | 12,070,589,241.26 | 13,251,864,916.69 |
| 流动负债: | | | | |
| 短期借款 | 336,796,462.44 | 375,587,009.74 | 163,425,294.93 | - |
| 应付票据及应付账款 | 1,278,982,594.25 | 1,295,952,315.46 | 1,368,004,694.84 | 1,337,852,488.29 |
| 其中：应付票据 | 4,607,840 | 43,197,065.04 | 38,791,871.74 | - |
| 应付账款 | 1,274,374,754.25 | 1,252,755,250.42 | 1,329,212,823.1 | 1,337,852,488.29 |
| 预收款项 | 5,367.06 | 4,498.42 | 5,449.6 | 990.88 |
| 合同负债 | 22,017,270.66 | 15,955,902.57 | 17,704,233.73 | 28,466,329.51 |
| 应付职工薪酬 | 35,745,226.37 | 37,808,519.16 | 78,078,520 | 30,197,753.87 |
| 应交税费 | 26,252,971.6 | 23,382,345 | 23,475,633.56 | 23,531,092.61 |
| 其他应付款合计 | 42,188,337.86 | 62,787,569.88 | 111,139,098.39 | 56,422,145.97 |
| 应付股利 | - | - | 47,980,456.23 | - |
| 一年内到期的非流动负债 | 76,081,037.88 | 57,297,684.53 | 19,129,383.31 | 18,599,657.99 |
| 其他流动负债 | 132,422,950.87 | 133,142,328.23 | 156,161,076.34 | 183,356,627.92 |
| 流动负债合计 | 1,950,492,218.99 | 2,001,918,172.99 | 1,937,123,384.7 | 1,678,427,087.04 |
| 非流动负债: | | | | |
| 长期借款 | 836,260,227.37 | 917,260,221.31 | 189,560,221.31 | 233,997,556.27 |
| 租赁负债 | 7,835,014.48 | 12,818,026.49 | 16,518,506.21 | 19,646,874.98 |
| 预计负债 | 101,190,562.93 | 106,057,127.14 | 97,803,627.23 | 54,401,218.61 |
| 递延收益 | 259,706,257.12 | 260,525,157.27 | 276,769,358.52 | 256,645,425.59 |
| 递延所得税负债 | 13,286,395.48 | 16,235,512.21 | 16,422,146.95 | 65,541,387.82 |
| 非流动负债合计 | 1,218,278,457.38 | 1,312,896,044.42 | 597,073,860.22 | 630,232,463.27 |
| 负债合计 | 3,168,770,676.37 | 3,314,814,217.41 | 2,534,197,244.92 | 2,308,659,550.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,599,348,541 | 1,599,348,541 | 1,599,348,541 | 1,599,348,541 |
| 资本公积 | 1,918,892,209.89 | 2,090,137,555.85 | 3,413,546,936.76 | 4,548,884,512.54 |
| 其他综合收益 | 32,392.13 | - | 384,292,400 | 277,525,000 |
| 盈余公积 | 399,395,645.68 | 399,395,645.68 | 360,944,023.29 | 81,031,665.66 |
| 未分配利润 | 3,063,196,880.14 | 3,319,600,256.99 | 2,862,858,649.9 | 3,176,452,826.21 |
| 归属于母公司股东权益合计 | 6,980,865,668.84 | 7,408,481,999.52 | 8,620,990,550.95 | 9,683,242,545.41 |
| 少数股东权益 | 350,243,948.78 | 404,988,487.83 | 915,401,445.39 | 1,259,962,820.97 |
| 股东权益合计 | 7,331,109,617.62 | 7,813,470,487.35 | 9,536,391,996.34 | 10,943,205,366.38 |
| 负债和股东权益合计 | 10,499,880,293.99 | 11,128,284,704.76 | 12,070,589,241.26 | 13,251,864,916.69 |
| 公告日期 | 2026-08-29 | 2026-04-28 | 2026-03-28 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |